Assessment | N= 195* |
---|---|
Age (years) | 42.8 (12.4) |
Male gender (%) | 138 (71%) |
HLA-B27 positive (%) | 158 (84%) |
Symptoms duration (years) | 20.4 (12.9) |
Disease duration (years) | 11.0 (8.7) |
ASDAS-CRP | 2.7 (1.0) |
BASDAI (0-10) | 3.4 (2.0) |
BASFI (0-10) | 3.2 (2.5) |
BASMI (0-10) | 3.7 (1.5) |
CRP (mg/l) (N = 186) | 17.5 (23.5) |
Elevated CRP (%)‡ | 96 (52%) |
mSASSS (0-72) (N = 177)¥ | 10.8 (15.2) |
RASSS (0-84) (N = 130) | 11.8 (16.6) |
mSASSS of patients with available RASSS (0-72) (N = 130) | 10.1 (14.2) |
mSASSS > 0 (%) (N = 177) | 143 (81%) |
RASSS > 0 (%) (N = 130) | 107 (82%) |
mSASSS > 0 of patients with available RASSS (%) (N = 130) | 106 (82%) |